The First AI-Native Oncology EHRbuilt for oncology practices, by oncologists.

Ambient documentation. Automated billing. Oncology-native workflows. Four AI agents share one clinical data model — so you can focus on patients, not paperwork.

See the workflowRequest a demo
BB
B. Baker
MRN 4847 · NSCLC · cycle 7
TUE · 10:42
Room 3 · cycle 7
74-year-old on osimertinib.
Returns with new fatigue.
LUNA AI
LISTENING
Deepgram ASR
MD“How’s the fatigue since last cycle?”
PT“Worse. I can barely get out of bed.”
MD“Let’s get a restaging scan.”
Luna structuring note
AI EXTRACTED
TOX Fatigue · grade 3 · new
ORDER CT c/a/p · priority
CODE 99214 · R53.83
MD · CHAT“Scan shows progression — what’s the next line?”
ATLAS AI · READING
Visit note
PET/CT · 04/24
Tumor board
NCCN NSCL-F
reasoningGemini LLM
AI RECOMMENDATIONNCCN · 1A
Ramucirumab + Docetaxel
2L · q21d × 4 cycles · confidence 0.94
PreviewApprove
PRIOR AUTH · RAMUCIRUMAB AI AUTO-FILLAetna · 47B
CHART
Dx✓
Labs✓
Imaging✓
Prior tx✓
PDF
READY
SEND
FAX
API
APPROVED ✓PA-2026-04-2847 · est 4h
LUNA · BACKGROUND AGENTClaude · Gemini
“Does B.B. qualify for any active trials?”
scanning 2,847 charts...
1match
NCT01293810 · infigratinib · FGFR3-altered urothelial
BB
B. BakerFGFR3 S249C · stage IV
94%
01Ambient
02Atlas
03Revenue
04Intel
AI-NATIVE · FOUR AGENTS · ONE DATA MODEL
End the day when you leave the clinic.
clinic out · 17:28 · 0 open notes · 0 after-hours charting
Tuesday · 10:42 AM · exam room 3
Inventory live at 27 clinic locations · Texas pilot
HIPAA seal
HIPAA
BAA available
AES-256 seal
AES-256
at rest & in transit
TEFCA seal
TEFCA
via CommonWell
GDPR seal
GDPR
EU data residency ready
CPRA seal
CPRA
California compliant
SOC 2 Type II seal
SOC 2 Type II
in progress · Q3 2026
ONC (g)(10) seal
ONC (g)(10)
in progress · roadmap on file
Watch · 90 seconds

See Wavera in motion.

One patient, one visit, four agents — the whole platform in ninety seconds.

How Wavera unifies data

Purpose-built for every workflow in cancer care.

Four specialized AI agents that share a single clinical, financial, and operational data model — so a dose change updates the schedule, the claim, and the forecast in one write.

01
Unified patient recordCore
BB
Barbara Baker
64 F with lung cancer
UNIFIED RECORD
Wavera
ingesting…
Connected engines
CommonwellELLKAYQuestLabCorpPACSDirect
FoundationOne CDx
ELLKAY
PET / CT report
PACS
Outside labs
Quest
Medication history
LabCorp
Hospitalization
Commonwell
Paper records
SCAN
Direct
Clinic notes
S
O
A
P
ELLKAY
BB
Barbara Baker
64 F with lung cancer · 7 sources unified
Wavera unified record
Oncology history
ListTimeline
Cancer diagnosis
extracted
NSCLC · adenocarcinoma
StageIV (T2bN2M1c)
SiteRUL → liver, bone
ICDC34.11
Genomic findings
FoundationOne
KEAP1p.G364C · pathogenic
SMARCA4p.R1135* · loss-of-function
TP53p.R273H · pathogenic
EGFR · ALK · ROS1wild-type
TMB19 mut/Mb · TMB-high

One record. Every source. Built in minutes.

Pull a new patient's full history from PACS, FoundationOne, hospital networks, outside labs, paper records, and pharmacy fills — automatically. Wavera unifies it into a single chart with an oncology timeline, extracted diagnosis and stage, and structured genomic findings.

  • 7+ source types ingested automatically
  • Auto-extracted diagnosis, stage, and biomarkers
  • Oncology-aware timeline of every event
  • Connected via Commonwell, ELLKAY, Quest, LabCorp, PACS
See it unify a record
Core platform · Unified Record
02
Ambient Charting
LUNA · LISTENING
Patient“I’ve had 4 episodes of diarrhea every day.”
Physician“Let’s get a CBC and a chem panel.”
Physician“We have to hold your treatment.”
VISIT NOTE · B. BAKERLIVE
INTERVAL HISTORY
Grade II diarrhea · iRAE
VITALS
BP 128/82 · HR 88 · T 99.1
ASSESSMENT
Hold immunotherapy
Order CBC + CMP
BILLING & DIAGNOSIS CODES
99214R19.7T45.1X5A

Real-time ambient dictation and action extraction.

Take our voice AI agent Luna into the room with you, or dictate after. Luna writes your note, queues up lab orders, and suggests diagnosis and billing codes — in seconds.

  • More time at the bedside
  • Less after-hours documentation
  • Reduces click burden
  • Diagnosis codes captured automatically
See Luna in your clinic
Ambient Charting · via Voice AI Agent
03
Atlas treatment manager
Physician“Patient progressed — what’s the next standard treatment?”
LunaReading 5 sources · anchoring to NCCN
SOURCES · 5
Visit Note
C34.11 · 04/20
Pathology Report
OCR · 04/18
Treatment History
Prior cycles · 04/15
PET CT
Imaging · 04/15
NCCN NSCLC
v3.2026
RECOMMENDATIONNCCN · 1A
Ramucirumab + Docetaxel
2L · NSCLC · post-platinum
Source · 5 docs · confidence 0.94
REGIMEN · DAY 1 · q21dPREVIEW
AGENT
DOSE
TIMING
Ramucirumab
10 mg/kg IV
60 min
Docetaxel
75 mg/m² IV
60 min
Dexamethasone
8 mg PO
Pre-med
Ondansetron
16 mg PO
Pre-med
INFUSION TIMELINE · CYCLE 1 · q21d~2h 45m chair
0:000:301:001:302:002:45
Port
Flush · NS
Pre-med
Dex 8mg · Zofran 16mg · Benadryl
Ramu
10 mg/kg IV · 60 min
Doc
75 mg/m² IV · 60 min
Watch
15 min post-infusion
▾vitals▾vitals▾vitals▾vitals
Labs: CBC & CMP 48h prior
Hold if ANC < 1500 or Plt < 100k
MD on-call: Dr. Sridhar · bleep 2294
✓ACTIVE PLAN · 4 CYCLES · q21dLIVE
C1
Apr 25
Chair 3
C2
May 16
Chair 2
C3
Jun 06
Chair 3
C4
Jun 27
Chair 2
DOSE · BSA 1.76Ramu 790 mg · Doc 132 mg / cycle
PRE-LABSCBC + CMP auto-ordered 48h before each cycle
NEXT SCANCT c/a/p · Jun 13 · after C3
INVENTORY4 cycles · reserved · $32,418 ordered✓

Build guideline-aligned regimens through natural language.

Ask in plain language. Luna pulls context from notes, imaging, and prior treatments, then anchors to the current NCCN guideline and proposes a regimen. Preview the orders, approve in one click, and Wavera schedules the cycles, arms lab holds, and tracks cumulative dose so cytopenia adjustments are made for you.

  • NCCN-aligned recommendations
  • One-click approval workflow
  • Cumulative dose tracking
  • No chart mining
Build a regimen in chat
Treatment Orchestration · Atlas agent
04
Revenue cycle agent
PRIOR AUTH REQUESTOxaliplatin · FOLFOX · 85 mg/m² IV × 12Aetna · plan 47B
PATIENT CHARTB. Baker · MRN 4847
PROBLEMS
C18.9 · Adenoca. colon, metastatic
Stage IV · T3 N1 M1
LABORATORY
CEA 47 ng/mL ↑
CBC wnl · LFTs wnl · Cr 1.1
IMAGING
PET/CT · 04/15 · 3 liver mets
Lesions 2-4 cm · progressing
PRIOR THERAPY
FOLFIRI × 8 cycles · progressed 03/26
Bevacizumab × 4
PROVIDER
Dr. Santos · Medical Oncology
NPI 1234567890 · DEA AS1234567
PRIOR AUTH · PA-47Bauto-generated
REQUEST · OXALIPLATIN 85 mg/m² IV · q14d × 12
DIAGNOSIS
LABORATORY
IMAGING
PRIOR TX
PROVIDER SIG
READY TO TRANSMIT
TRANSMITTING · PA-2026-04-28472 channels · parallel
PDF PACKET4 pp · 248 KB
FAX
Automated Fax
1-800-555-0142 · Aetna RX
API
Availity Essentials
x12 · 278 submission · secure
AETNA PAYER PORTAL · MONITORLIVE
PA-2026-04-2847ETA 4h · Aetna · plan 47B
Received by Aetna
04/24 · 14:32
Clinical review
pending
Decision pending
—
Approved
—
Auto-refill scheduled · claim primedAPPROVED ✓

Prior auths that write and submit themselves.

When a regimen needs a PA, Luna reads the chart, fills the payer form, and transmits it through fax and Availity in parallel. You sign off when it lands back approved.

  • Zero end-of-week reconciliation
  • Auto-fill from chart
  • Fax + Availity in parallel
  • Fewer denials, faster cash
Audit your PA & J-code leakage
Revenue Cycle · via Prior-Auth Agent
05
Practice intelligenceSuperpower
PRACTICE INTELLIGENCELUNA · TENANT-WIDE
PhysicianShow me all patients who could qualify for NCT01293810.
Luna
NCT01293810 · infigratinib · FGFR3-altered urothelial · phase II
Complete · 8 candidates match all criteria
15s
8matches
2,847screened
0.3%hit rate
27clinics
B.K.94%
Urothelial · IV
FGFR3 S249C
S.R.91%
Urothelial · III
FGFR3 R248C
M.C.87%
Upper tract uroth.
FGFR3 Y375C
A.P.84%
Urothelial · progressed
FGFR3-TACC3
+ 4 more · view all
PhysicianWhich regimens drove our margin this quarter?
Luna
MARGIN · Q2 2026 · TOP 5 · vs Q1
72%
↑ 8%
Keytruda
58%
↑ 12%
Oxaliplatin
46%
↑ 2%
Rituximab
38%
↓ 4%
Docetaxel
22%
↓ 1%
Leucovorin
PhysicianForecast pembrolizumab demand · next 90 days.
Luna
PEMBROLIZUMAB · DEMAND · 18 WEEKS · 90-DAY FORECAST
NOW
past 6w · 18u forecast · 24u+18% vs. q1 · restock due week 3
agents running · 4 services · 27 clinic locations · 2,847 charts indexed

Ask your entire practice a question.

Forecast drug demand, find trial candidates, surface unbilled visits, spot charting gaps — all with agents that run in the background while you see patients.

  • Answers anyone in seconds
  • No data team required
  • Catches trial candidates early
  • Spots revenue leaks
Ask your tenant anything
Practice Intelligence · Tenant-wide agents
Interoperability

Every system that matters, plugged into one core.

One platform, fourteen partners — health data exchange, oncology guidelines, precision labs, AI reasoning, ambient voice, and the full Rx-to-payment loop — all wired through FHIR, HL7, and direct API. Hover any node to inspect the connection.

CORE PLATFORM
Wavera
EHRInventoryConnect
DATA EXCHANGE
DATA EXCHANGEGUIDELINE GROUNDINGPRECISION LABSREASONING ENGINEAMBIENT VOICEBILLING · RX · PAYMENTS
26 FHIR R4 resource typesUS Core 7.0.0TEFCA · via CommonWellCarequality-connectedSMART on FHIR
Our team

The team building this has lived the problem.

Founded in 2026, Wavera is built by engineers, clinicians, and operators who understand the realities of oncology practice.

Wei Yang, M.D.

Wei Yang, M.D.

CEO & Founder
Practicing oncologist and AI engineer, bridging gap in health and tech with deep industry expertise across clinical operations, AI systems and health-tech product development.
LinkedIn
Ananth Sivasubramanian

Ananth Sivasubramanian

Chief Technology Officer
Seasoned engineering leader with deep expertise in distributed systems, cloud infrastructure, and building scalable health-tech platforms.
LinkedIn
Arthi Sridhar, M.D.

Arthi Sridhar, M.D.

Chief Medical Advisor
Practicing oncologist bringing frontline clinical insight to ensure Wavera's tools are grounded in real-world patient care workflows.
LinkedIn

Interested in seeing it?
Bring your hardest workflow.

30-minute walkthrough with a founder. No PHI exchanged. No pressure.

Request a demoSee use cases